Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008
Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design
WALTER P. MAKSYMOWYCH, OLIVER FITZGERALD, GEORGE A. WELLS, DAFNA D. GLADMAN, ROBERT LANDEWÉ, MIKKEL ØSTERGAARD, WILLIAM J. TAYLOR, ROBIN CHRISTENSEN, PAUL-PETER TAK, MAARTEN BOERS, SILJE W. SYVERSEN, JOAN M. BATHON, CHRISTOPHER J. RITCHLIN, PHILIP J. MEASE, VIVIEN P. BYKERK, PATRICK GARNERO, PIET GEUSENS, HANI EL-GABALAWY, DANIEL ALETAHA, ROBERT D. INMAN, VIRGINIA BYERS KRAUS, TORE K. KVIEN and DÉSIRÉE van der HEIJDE
The Journal of Rheumatology August 2009, 36 (8) 1792-1799; DOI: https://doi.org/10.3899/jrheum090347
WALTER P. MAKSYMOWYCH
OLIVER FITZGERALD
GEORGE A. WELLS
DAFNA D. GLADMAN
ROBERT LANDEWÉ
MIKKEL ØSTERGAARD
WILLIAM J. TAYLOR
ROBIN CHRISTENSEN
PAUL-PETER TAK
MAARTEN BOERS
SILJE W. SYVERSEN
JOAN M. BATHON
CHRISTOPHER J. RITCHLIN
PHILIP J. MEASE
VIVIEN P. BYKERK
PATRICK GARNERO
PIET GEUSENS
HANI EL-GABALAWY
DANIEL ALETAHA
ROBERT D. INMAN
VIRGINIA BYERS KRAUS
TORE K. KVIEN
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design
WALTER P. MAKSYMOWYCH, OLIVER FITZGERALD, GEORGE A. WELLS, DAFNA D. GLADMAN, ROBERT LANDEWÉ, MIKKEL ØSTERGAARD, WILLIAM J. TAYLOR, ROBIN CHRISTENSEN, PAUL-PETER TAK, MAARTEN BOERS, SILJE W. SYVERSEN, JOAN M. BATHON, CHRISTOPHER J. RITCHLIN, PHILIP J. MEASE, VIVIEN P. BYKERK, PATRICK GARNERO, PIET GEUSENS, HANI EL-GABALAWY, DANIEL ALETAHA, ROBERT D. INMAN, VIRGINIA BYERS KRAUS, TORE K. KVIEN, DÉSIRÉE van der HEIJDE
The Journal of Rheumatology Aug 2009, 36 (8) 1792-1799; DOI: 10.3899/jrheum090347
Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design
WALTER P. MAKSYMOWYCH, OLIVER FITZGERALD, GEORGE A. WELLS, DAFNA D. GLADMAN, ROBERT LANDEWÉ, MIKKEL ØSTERGAARD, WILLIAM J. TAYLOR, ROBIN CHRISTENSEN, PAUL-PETER TAK, MAARTEN BOERS, SILJE W. SYVERSEN, JOAN M. BATHON, CHRISTOPHER J. RITCHLIN, PHILIP J. MEASE, VIVIEN P. BYKERK, PATRICK GARNERO, PIET GEUSENS, HANI EL-GABALAWY, DANIEL ALETAHA, ROBERT D. INMAN, VIRGINIA BYERS KRAUS, TORE K. KVIEN, DÉSIRÉE van der HEIJDE
The Journal of Rheumatology Aug 2009, 36 (8) 1792-1799; DOI: 10.3899/jrheum090347